UNSPSC 51284042: Tetracycline guaiacolsulfonate

This classification denotes a tetracycline antibiotic C22H24N2O8.C7H8O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 05T77P89WE, chemically known as 4-hydroxy-3-methoxybenzenesulfonic acid, (2z,4s,4as,5as,6r,12as)-2-(amino(hydroxy)methylidene)-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-6-methyl-4a,5a,6,12a-tetrahydrotetracene-1,3,12(2h,4h,5h)-trione (1:1), but more generally known as tetracycline guaiacolsulfonate, which bears US NIH Compound Identifier 71300435.

UNSPSC 51284042 Tetracycline guaiacolsulfonate is a Commodity code that nominally identifies a specific pharmaceutical active ingredient, but recent state and local solicitations tagged with this code show minimal alignment with the ingredient itself. Instead, the opportunities posted under this code span a wider range of pharmaceutical procurement activities including naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals with over-the-counter products. The issuing bodies include county health departments, state health and human services commissions, municipal fire departments, and cooperative purchasing alliances representing multiple states and localities. The scope reflects broader pharmaceutical and medical supply procurement rather than procurement of tetracycline guaiacolsulfonate as a distinct product line.

Recent activity shows geographic spread across Florida, Texas, and Minnesota-Oregon cooperative arrangements. Representative opportunities include Seminole County, Florida's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the Texas Health and Human Services Commission's RFI HHS0017013 (posted April 3, 2026) exploring direct-to-manufacturer prescription program capabilities; the City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies estimated at $700,000 and sheltered for certified Small Local Business Enterprises with a 5 percent bid discount; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers. The code shows limited recent activity directly tied to tetracycline guaiacolsulfonate procurement.